EN PL

MHRA: Adverse drug reactions: Update on Anonymised Single Patient Reports (ASPRs): July 2010

04.08.2010
The MHRA has implemented a series of changes to the logic which defines which marketing authorisation holders (MAHs) receive ASPRs/Individual Case Safety Reports (ICSRs). It is expected that these changes will result in a reduction in the number of ASPRs/ICSRs that MAHs receive.